₹1430.603.900.27%(1D)
Performance Stats for Emcure Pharmaceuticals
Day Range
Low: ₹1422.40
High: ₹1440.50
52 Week Range
Low: ₹889.00
High: ₹1585.60
Open Price
1440.50Previous Close
1434.50Volume
33634.00Open Price
1440.50Previous Close
1434.50Volume
33634.00Fundamentals of Emcure Pharmaceuticals
ROCE
14.36%
EPS
₹35.05
Dividend Yield
0.28%
P/E Ratio
64.09
P/B Ratio
6.72
Debt to Equity
0.49
Current Ratio
1.17
Sales Growth
26.14%
Profit Growth
209.28%
EBIT Growth
129.21%
Financials of Emcure Pharmaceuticals
All values in Rs. Cr
All values in Rs. Cr
All values in Rs. Cr
Share Holding Pattern of Emcure Pharmaceuticals
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited, as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay. Subse...
Read more
Similar Sector Stocks
| Stocks | CMP |
| Aarti Pharmalabs | ₹706.85 2.31% |
| Akums Drugs And Pharma | ₹482.15 0.32% |
| Albert David | ₹728.6 2.55% |
| Alivus Life Sciences | ₹905 2.42% |
Most Viewed Stocks
Sorry, option data not Found For this Stock :(
Events Related to Emcure Pharmaceuticals
Board Meeting
Feb 4, 2026
Board Meeting
Nov 11, 2025
AGM
Aug 28, 2025
Dividend
Aug 14, 2025
Board Meeting
Aug 7, 2025
News About Emcure Pharmaceuticals
Buy, Sell Or Hold: L&T, TCS, Emcure Pharmaceuticals, Tata Motors — Ask Profit
Feb 16, 2026
MSCI Rejig: 7 smallcap stocks included in latest shuffle. Do you own any?
Feb 11, 2026
Q3 Results Today: Bajaj Finserv, JSW Cement, Tata Power, Trent Among Over 140 Companies To Declare Earnings On Feb. 4
Feb 4, 2026
Emcure Pharma shares in focus after GST Department conducts search at Mumbai offices
Nov 28, 2025
Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growth
Aug 7, 2025
